(Q51963735)

19 April 2018

title

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia. (English)

1 reference

19 April 2018

0 references

0 references

5

Heinrich Sauer

1 reference

19 April 2018

Stefan Smesny

1

object named as

Stefan Smesny

1 reference

19 April 2018

author name string

Susan Stein

2

1 reference

19 April 2018

Ingo Willhardt

3

1 reference

19 April 2018

Jürgen Lasch

4

1 reference

19 April 2018

publication date

27 June 2008

1 reference

19 April 2018

Journal of Neural Transmission

published in

1 reference

19 April 2018

volume

115

1 reference

19 April 2018

issue

8

1 reference

19 April 2018

page(s)

1173-1179

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1007/s00702-008-0081-0

exact match

0 references

cites work

Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

Factors determining the decision to institutionalize dementing individuals: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

The expanding superfamily of phospholipase A(2) enzymes: classification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

Phospolipase A2 and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0081-0

[The neural basis of learning and memory declines in aged rats]

21 January 2018

1 reference

12 December 2020

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

1 reference

12 December 2020

Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line

1 reference

12 December 2020

4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

1 reference

12 December 2020

Conformational changes in oxidized phospholipids and their preferential hydrolysis by phospholipase A2: a monolayer study

1 reference

12 December 2020

[Alzheimer's disease versus vascular dementia -- dichotomy or interaction?]

1 reference

12 December 2020

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

12 December 2020

Phospholipaise A2 and arachidonic acid-mediated mechanism of neuroexocytosis: a possible target of botidinum neurotoxin A other then SNAP-25

1 reference

12 December 2020

Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipids

1 reference

12 December 2020

Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.

1 reference

12 December 2020

Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices

1 reference

12 December 2020

Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia

1 reference

12 December 2020

Pardaxin stimulation of phospholipases A2 and their involvement in exocytosis in PC-12 cells

1 reference

12 December 2020

1 reference

12 December 2020

Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2

1 reference

12 December 2020

A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols

1 reference

12 December 2020

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

1 reference

12 December 2020

Biochemical aspects of neurodegeneration in human brain: involvement of neural membrane phospholipids and phospholipases A2.

1 reference

12 December 2020

Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients

1 reference

12 December 2020

Altered mitochondrial membrane fluidity in AD brain.

1 reference

12 December 2020

[Relevance of metabolism of membrane phospholipids for Alzheimer dementia].

1 reference

12 December 2020

Regulation and inhibition of phospholipase A2.

1 reference

12 December 2020

Alzheimer Disease and Oxidative Stress

1 reference

12 December 2020

Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy

1 reference

12 December 2020

Inhibitors of phospholipase A2 produce amnesia for a passive avoidance task in the chick

1 reference

12 December 2020

The role of phospholipases A2 in schizophrenia

1 reference

12 December 2020

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

1 reference

12 December 2020

Increased serum phospholipase A2 activity in schizophrenia: a replication study.

1 reference

12 December 2020

Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory

1 reference

12 December 2020

Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia

1 reference

12 December 2020

[Dementia syndrome and Alzheimer disease: an assessment of morbidity and annual incidence in Germany]

1 reference

12 December 2020

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

12 December 2020

Ca2+-independent phospholipase A2 inhibitor impairs spatial memory of mice.

1 reference

12 December 2020

Increased phospholipase A2 activity in schizophrenia with absent response to niacin

1 reference

12 December 2020

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

1 reference

12 December 2020

Cortical plasticity in Alzheimer's disease in humans and rodents.

1 reference

12 December 2020

The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

1 reference

12 December 2020

Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice

1 reference

12 December 2020

Long-term potentiation requires activation of calcium-independent phospholipase A2

1 reference

12 December 2020

Functional neurochemistry of Alzheimer's disease

1 reference

12 December 2020

Protease activation of calcium-independent phospholipase A2 leads to neutrophil recruitment to coronary artery endothelial cells

1 reference

12 December 2020

Enhanced interfacial catalysis and hydrolytic specificity of phospholipase A2 toward peroxidized phosphatidylcholine vesicles

1 reference

12 December 2020

Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders

1 reference

12 December 2020

No differences in phospholipase-A2 activity between acute psychiatric patients and controls.

1 reference

12 December 2020

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

1 reference

12 December 2020

1 reference

12 December 2020

Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits

1 reference

12 December 2020

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

12 December 2020

Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1

1 reference

12 December 2020

Clock-drawing: is it the ideal cognitive screening test?

1 reference

12 December 2020

Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain.

1 reference

12 December 2020

Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats

1 reference

12 December 2020

Plasma membrane ordering agent pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rats

1 reference

12 December 2020

A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex

1 reference

12 December 2020

Inhibitors of PLA2 and NO synthase cooperate in producing amnesia of a spatial task.

1 reference

12 December 2020

Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus

1 reference

12 December 2020

Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease

1 reference

12 December 2020

Diversity of group types, regulation, and function of phospholipase A2

1 reference

12 December 2020

Alzheimer disease and cerebrovascular pathology: an update

1 reference

12 December 2020

Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment

1 reference

12 December 2020

Overlap between pathology of Alzheimer disease and vascular dementia

1 reference

12 December 2020

Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice.

1 reference

12 December 2020

Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity

1 reference

12 December 2020

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

1 reference

12 December 2020

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases

1 reference

12 December 2020

Identification of calcium-independent phospholipase A2 (iPLA2) beta, and not iPLA2gamma, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammali

1 reference

12 December 2020

The clock drawing test and questionable dementia: reliability and validity.

1 reference

12 December 2020

Loss of cholinergic pathways in vascular dementia of the Binswanger type.

1 reference

12 December 2020

10.1007/S00702-008-0081-0

Identifiers

DOI

1 reference

19 April 2018

release_er42ypf7obcopbzfe562xr7rm4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/er42ypf7obcopbzfe562xr7rm4

24 November 2022

mapped directly with Wikidata item

1 reference

19 April 2018